Please try another search
On Friday, Citi reaffirmed its Buy rating and DKK975.00 price target for Novo Nordisk (NOVOB:DC) (NYSE:NVO), a global healthcare company specializing in diabetes care and other serious chronic...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review